Desloratadine Actavis Den Europæiske Union - engelsk - EMA (European Medicines Agency)

desloratadine actavis

actavis group ptc ehf - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamines for systemic use, - treatment of allergic rhinitis and urticaria.

Desloratadine Teva Den Europæiske Union - engelsk - EMA (European Medicines Agency)

desloratadine teva

teva b.v - desloratadine - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - antihistamines for systemic use, - desloratadine teva is indicated for the relief of symptoms associated with:allergic rhinitis;urticaria.

Docetaxel Teva Pharma Den Europæiske Union - engelsk - EMA (European Medicines Agency)

docetaxel teva pharma

teva pharma b.v. - docetaxel - carcinoma, non-small-cell lung; breast neoplasms; prostatic neoplasms - antineoplastic agents - breast cancerdocetaxel teva pharma monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.non-small-cell lung cancerdocetaxel teva pharma is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer after failure of prior chemotherapy.docetaxel teva pharma in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small-cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancerdocetaxel teva pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.

COBAN 90- monensin granule USA - engelsk - NLM (National Library of Medicine)

coban 90- monensin granule

elanco us inc. - monensin (unii: 906o0yj6zp) (monensin - unii:906o0yj6zp) - monensin 200 g in 1 kg - pollos de engorde de reemplazo y gallinas ponedoras de reemplazo y pollos reproductores ponedores de reemplazo: como ayuda para prevenir la coccidiosis provocada por eimeria necatrix, e. tenella, e. acervulina, e. brunetti, e. mivati, y e. maxima . pavos: para la prevención de coccidiosis en pavos causada por eimeria adenoeides , e. meleagrimitis y e. gallopavonis . codornices: para la prevención de coccidiosis en codornices de crianza causadas por eimeria dispersa y e. lettyae . importante: debe mezclarse bien con los alimentos antes de usar. mezclar completamente coban 90 con una pequeña cantidad de alimento no medicamentoso (p. ej., 1 lb con 100-200 lb) antes de la incorporación en el alimento medicamentoso de tipo c. instrucciones de mezcla (pollos de engorde y gallinas ponedoras de reemplazo y gallinas reproductoras ponedoras de reemplazo) - mezclar completamente coban 90 con una cantidad suficiente de alimento no medicamentoso para generar una tonelada de alimento para pollos que brinda entre 90

Lemtrada 12 mg concentrate for solution for infusion Den Europæiske Union - engelsk - myHealthbox

lemtrada 12 mg concentrate for solution for infusion

genzyme therapeutics ltd - alemtuzumab - concentrate for solution for infusion - 12 mg alemtuzumab in 1.2 ml (10 mg/ml) - multiple sclerosis - selective immunosuppressants - indicated for adult patients with relapsing remitting multiple sclerosis (rrms) with active disease defined by clinical or imaging features

Clopidogrel/Acetylsalicylic acid Teva Den Europæiske Union - engelsk - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid teva

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

DuoPlavin Den Europæiske Union - engelsk - EMA (European Medicines Agency)

duoplavin

sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - duoplavin is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy.for further information please refer to section 5.1.

Xigris Den Europæiske Union - engelsk - EMA (European Medicines Agency)

xigris

eli lilly nederland b.v. - drotrecogin alfa (activated) - sepsis; multiple organ failure - antithrombotic agents - xigris is indicated for the treatment of adult patients with severe sepsis with multiple organ failure when added to best standard care. the use of xigris should be considered mainly in situations when therapy can be started within 24 hours after the onset of organ failure (for further information see section 5.1).

Ultibro Breezhaler 85 micrograms/43 micrograms, inhalation powder hard capsules Den Europæiske Union - engelsk - myHealthbox

ultibro breezhaler 85 micrograms/43 micrograms, inhalation powder hard capsules

novartis europharm limited - indacaterol, glycopyrronium bromide - inhalation powder, hard capsule - 110 microgram indacaterol and 50 microgram glycopyrronium - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)